This configuration is beneficial when targeting high levels of organic or pathogen removal but may require more complex controls and instrumentation
Custom battery design can optimize the balance between discharge performance, capacity, size, and lifespan
In the multiple-ascending-dose arm at steady state (Day 28), the mean half-life increased to 48.1 to 67.5 hours across doses, reflecting the accumulation kinetics of a compound with nonlinear pharmacokinetics
Sitagliptin (Januvia), the first in a new class of antihyperglycemic agents, was approved in October 2006
Cell Signal 42:281291
At the other end of the spectrum, BPC-157 is a synthetic peptide sold as a research chemical, with no regulatory approval and no completed controlled human trial data